What is the role of the endocannabinoid system (eCS) on the lipopolysaccharide (LPS) effects on uterine explants from 7-day pregnant mice in a murine model of endotoxin-induced miscarriage?
Introduction
Gram-negative bacterial infections of the genital tract are associated with increased risk of early pregnancy loss and represent one of the most common complications in human pregnancy (Nigro et al., 2011) . According to Giakoumelou et al. (2016) , potentially preventable infections may account for up to 15% of early miscarriages and up to 66% of late miscarriages. Infectious agents can colonize the choriodecidual space early in gestation and infect the fetal membranes, placenta, amniotic fluid and embryo via the vagina and cervix, or via hematogenous dissemination after maternal infection of distant tissues, or iatrogenically (Goldenberg et al., 2000; Gonçalves et al., 2002) . The presence of lipopolysaccharide (LPS), a component of the cell wall of Gram-negative bacteria (which are responsible for the majority of genital infections), has been associated with miscarriage (Aisemberg et al., 2010) . Previous results from our laboratory have shown that systemic exposure to LPS is associated with increased leukocyte infiltration of the decidua (Ogando et al., 2003) , increased uterine and decidual nitric oxide (NO), prostaglandin, cytokine and chemokine production (Ogando et al., 2003; Aisemberg et al., 2007; Wolfson et al., 2015a) , premature luteal regression (Schander et al., 2016) and lower levels plasma levels of progesterone (Aisemberg et al., 2013; Wolfson et al., 2015a; Schander et al., 2016) . These changes resulted in an increased embryotoxicity with a higher rate of embryonic resorption and fetal expulsion (Ogando et al., 2003; Aisemberg et al., 2012 Aisemberg et al., , 2013 Wolfson et al., 2015a) .
Uterine quiescence is of paramount importance for a successful pregnancy. Exposure to LPS induces an increase in uterine contractility via different mechanisms (Mackler et al., 2003; Ross et al., 2004; Adams Waldorf et al., 2008; Hutchinson et al., 2014) , including a higher production of prostaglandin-F 2α (PGF 2α ) (Aisemberg et al., 2007; Hutchinson et al., 2014) . This LPS-induced increased uterine contractibility is associated with pregnancy loss (Anbe et al., 2007; Agrawal and Hirsch, 2012) . Cyclic adenosine monophosphate (cAMP) is a second messenger with an important role in the maintenance of myometrial relaxation (Price and Bernal, 2001; Yuan and López Bernal, 2007) , as well as other processes such as decidualization of human endometrium (Brar et al., 1997) and implantation (Kusama et al., 2015) . Interestingly, it has been shown that cAMP is involved in prostaglandin production by modulating ciclooxygenase-2 expression in human myometrial cells (Chen et al., 2012) , suggesting a complex bidirectional relationship between utero-relaxant and uterotonic agents.
Cumulative evidence points toward the participation of the endocannabinoid system (eCS) in early pregnancy loss (reviewed in Correa et al., 2016) . Indeed, increased local anandamide (AEA) levels are embryotoxic and lead to pregnancy failure (Paria and Dey, 2000) and high plasma levels of AEA have been shown in women who have miscarried (Habayeb et al., 2008) . Moreover, Sun et al. (2016) have recently reported that a sustained endocannabinoid signaling is involved in premature decidual senescence. Furthermore, we have previously shown that both CB1 and CB2 receptors are expressed in the uterus and that the eCS mediates the deleterious effects of LPS on reproductive tissues by participating in the endotoxin-induced production of NO and prostaglandin (Vercelli et al., 2009a (Vercelli et al., ,b, 2012 Wolfson et al., 2015b) . Furthermore, we have previously shown that CB1-KO mice are resistant to LPS-induced embryo resorption (Wolfson et al., 2015a) and that a sustained activation of endocannabinoid signaling via CB1 promotes inflammation-induced preterm birth (Sun et al., 2016) . Moreover, cumulative evidence points toward the involvement of CB1 receptor activation in mediating LPS deleterious effects on uterine (Vercelli et al., 2009b) and decidual tissues (Vercelli et al., 2009a) . Conversely, the contribution of the CB2 receptor to LPS effects on pregnancy remains elusive.
The main aim of this work was to explore the participation of the eCS in mediating the effects of LPS on PGF 2α production and cAMP intracellular content of uterine explants from early pregnant mice.
Materials and Methods

Reagents
LPS from Escherichia coli 05:B55, R(+)-methanandamide (m-AEA), cAMP, forskolin and 3-isobutyl-1-methylxanthine (IBMX) were purchased from Sigma Chemical Co. (St Louis, MI, USA). AM251 and AM630 were obtained from Tocris Cookson Inc. (Ellisville, MO, USA). [5,6,8,9,11,12,14,15 (n)-3 H]-prostaglandin-F 2α (160 Ci/mmol, 200 μCi/ml) was provided by Perkin Elmer (Boston, MA, USA). Dulbecco's modified Eagle's medium (DMEM) and Penicillin-Streptomycin Solution were from Invitrogen (Life Technologies, Argentina). Fetal bovine serum (FBS) was from Internegocios SA (Mercedes, Buenos Aires, Argentina). All other chemicals were analytical grade.
Animals and uterine explants preparation
Eight to 12-week-old virgin female BALB/c or CD1 (wild-type [WT] or CB1-knockout [CB1-KO]) mice were paired with 8-to 12-week-old BALB/c or CD1 (WT or CB1-KO) males, respectively. The day of appearance of a coital plug was taken as day 0 of pregnancy. Animals were housed in cages under controlled conditions of light (12 h light, 12 h dark) and temperature (21-25°C) and received murine chow and water ad libitum.
On day 7 of pregnancy, BALB/c, CD1 WT or CD1 CB1-KO mice were euthanized by cervical dislocation. The uteri were excised and the implantation sites were conserved. Next, decidual and embryo tissues were separated from the underlying uterine tissue and discarded. The authors use the terms 'uterus' and 'uterine tissue' for the tissue composed of nondecidualized endometrium, myometrium and adventitia/serosa. Uterine explants were weighed and then cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin (v/v) in a humidified environment containing 5% CO 2 and held at a constant temperature of 37°C.
Ethics statement
The experimental procedures reported here were approved by the Animal Care Committee of the Center for Pharmacological and Botanical Studies of the National Research Council (CEFYBO -CONICET) (Resolution Number 900/2016) and by The Institutional Committed for the Care and Use of Laboratory animals from the School of Medicine (University of Buenos Aires), and were carried out in accordance with the Guide for Care and Use of Laboratory Animals (NIH).
Camp assay
Uterine strips were preincubated for 3 min with 800 μM IBMX at 37°C (t = 0) followed by incubation for 10 min with different stimuli. At the appropriate time, uterine strips were homogenized in ice-cold phosphate buffer (50 mM, pH 7.4) with 5 mM EDTA. Next, 5 ml of ice-cold ethanol was added in order to preserve the intracellular cAMP levels and samples were stored at −80°C until further use. On the day of the assay, tubes were centrifuged at 1000g for 10 min at 4°C. The ethanolic supernatant was separated from the precipitated protein pellet. The ethanol was evaporated from the supernatants and residues were resuspended in 50 mM Tris-HCl, pH 7.4, 0.1% BSA for cAMP determination. Cyclic AMP levels were measured by competitive radio-binding assay to the regulatory subunit of PKA using [ 3 H]cAMP, as previously described (Davio et al., 1995) . The relative cAMP levels were normalized to the corresponding wet tissue weight (pmoles of cAMP/mg wet tissue).
Radioimmunoassay
Uterine explants were incubated for 6 h in the presence or absence of LPS (1 μg/ml) or forskolin (0.033, 0.33, 3.3 and 33 μM). At the appropriate time, supernatants were collected and processed for PGF 2α determination by radioimmunoassay as previously described (Campbell and Ojeda, 1987) . PGF 2α antiserum was highly specific for PGF 2α and showed low cross-reactivity with related compounds. Sensitivity was 5-10 pg per tube and K a = 1.5 × 10 10 l/mol. Values are expressed as pg of PGF 2α /mg of wet tissue.
Statistical analyses
From each 7-day pregnant mice, enough uterine explants were obtained for all the treatments in each experiment. Therefore, statistical analysis was performed in blocks when necessary. Data were analyzed by means of one-way or two-way ANOVA procedures, and means were compared by Duncan post hoc test. The differences between means were considered significant when the P-value was 0.05 or less. Different letters indicate significant differences between means. Normality and homoscedasticity were tested by Shapiro-Wilk (modified) and Levene test, respectively. Statistical analysis was performed using the software Infostat (Córdoba, Argentina).
Results
Figure 1 shows that in vitro administration of LPS increased PGF 2α production ( Fig. 1A ) and diminished tissue content of cAMP (Fig. 1B ) in uterine explants from early pregnant BALB/c mice. To evaluate the participation of the eCS in LPS-induced PGF 2α production, uterine explants were incubated for 6 h with the endotoxin (1 μg/ml) in the presence or absence of 10 nM AM251 (a CB1 receptor antagonist) or 10 nM AM630 (a CB2 receptor antagonist). As shown in Fig. 1C , incubation of LPS with the CB1 receptor antagonist had no effects on LPS-induced PGF 2α production whereas the CB2 receptor antagonist partially reversed the effects of the endotoxin. Interestingly, when both antagonists were used, the reversion was complete, suggesting a contribution of both cannabinoid receptors, albeit slightly differently, to the effects of LPS.
In order to explore whether activation of the eCS could mediate LPS effects, we incubated uterine explants from early pregnant BALB/c mice with different concentrations of m-AEA (a nonhydrolysable anandamide analog). As shown in Fig. 2 , m-AEA induced an increase PGF 2α production ( Fig. 2A) and a reduction in tissue content of cAMP (Fig. 2B ) in uterine explants. Since both AEA and m-AEA also activate the transient receptor potential cation channel subfamily V member 1 (TRPV1), we performed experiments using the TRPV1 antagonist capsazepine. As shown in Supplementary Figure S1 , blocking TRPV1 with capsazepine was unable to prevent the LPS-induced reduction of the tissue content of cAMP in uterine explants from early pregnant mice.
In order to further explore the participation of cannabinoid receptors on the LPS-induced modulation of tissue content of cAMP in uterine explants, we proceeded to study whether the endotoxin had a similar effect on the uterine explants from CB1-KO mice. Since CB1-KO mice belong to the CD1 strain, our first approach was to compare the effects of LPS on the basal intracellular levels of cAMP in uterine explants from early pregnant CD1 WT and CD1 CB1-KO mice. As shown in Fig. 3A , in both WT and CB1-KO mice, 1 μg/ml LPS induced a reduction of the basal tissue content of cAMP in uterine explants. Similarly, in vitro treatment with different concentrations of m-AEA (10-1000 nM) resulted in lower basal intracellular levels of cAMP in uterine explants from early pregnant CD1 WT and CB1-KO mice (Fig. 3B) .
Due to the fact that we found an inverse relation between PGF 2α production and tissue content of cAMP, we decided to study whether pharmacologically increasing the intracellular levels of cAMP could impact the production of PGF 2α . We observed that 3.3 μM forskolin (an activator of the enzyme adenylyl cyclase) per se induced a reduction in the production of PGF 2α by uterine explants (Fig. 4A) . Moreover, forskolin significantly prevented the LPS-induced increase in PGF 2α production by uterine explants from early pregnant BALB/c mice (Fig. 4B) .
Since cannabinoid receptors are typically Gα i/o protein-coupled receptors, we decided to use 3.3 μM forskolin in our next set of experiments in order to have higher basal levels of cAMP. Forskolin-treated uterine explants from early pregnant BALB/c mice showed a diminished tissue content of cAMP when treated with 1 μg/ml LPS (Fig. 5A ) or 10-1000 nM m-AEA (Fig. 5B) . Next, we sought to investigate the participation of cannabinoid receptors on LPS effects on the intracellular content of cAMP in forskolin-treated uterine explants. As shown in Fig. 5C , we observed that CB1 receptor blockade with 10 nM AM251 failed to prevent the LPS-induced reduction of cAMP tissue content. However, CB2 receptor antagonism with 10 nM AM630 significantly prevented LPS effects. Similarly, blockade of both CB1 and CB2 receptors resulted in cAMP intracellular levels similar to control ones.
Next, we pretreated the uterine explants from CD1 WT and CB1-KO mice with 3.3 μM forskolin in order to increase the content of cAMP in these tissues. When forskolin-treated uterine explants were exposed to 1 μg/ml LPS, only tissues from CD1 WT mice showed a reduction in the intracellular levels cAMP (Fig. 6A) . Interestingly, when forskolin-treated uterine explants were exposed to different concentrations of m-AEA (1-1000 nM), we found that the tissue content of cAMP was reduced both in CD1 WT and CB1-KO mice. Since LPS only had an effect on forskolin-treated uterine explants from only CD1 WT mice, we performed the next experiment with that tissue. As shown in Fig. 6C , forskolin-treated uterine strips from CD1 WT mice showed a reduced content of cAMP in the presence of 1 μg/ml LPS. However, when CB2 receptors were blocked with 10 nM AM630, the effect of the endotoxin was prevented while the antagonism of CB1 receptors with 10 nM AM251 resulted in a partial reversion. When both receptors were blocked, the effect of LPS was completely prevented (Fig. 6C) .
Discussion
In the present study, we have shown that CB2 receptor is involved in LPS-mediated regulation of PGF 2α synthesis and cAMP intracellular content in uterine explants from early pregnant mice.
Several lines of research have shown a correlation between the eCS and early loss of pregnancy. Thus, Habayeb et al. (2008) reported that women with higher risk of miscarriage presented higher plasma levels of AEA while Taylor et al. (2011) found that women with nonviable first-trimester pregnancy had elevated serum levels of AEA when compared with those in women with viable pregnancies. Similarly, Maccarrone et al. (2000) showed a decreased fatty acid amide hydrolase (the main catabolic enzyme responsible of AEA degradation) activity in peripheral lymphocytes from women who miscarried. These observations suggest that overstimulation/dysregulation of the eCS might have deleterious effects on pregnancy. Previous results from our lab have shown that LPS administration to 7-day pregnant mice results in an increased production of endocannabinoids in the decidua, which resulted in an increased embryo resorption rate (Wolfson et al., 2015a) .
Although the role of CB1 receptor activation in reproductive tissues has been extensively studied (reviewed in Correa et al., 2016) , very little is known regarding the effects of CB2 receptor activation in these tissues. Trabucco et al. (2009) have shown that AEA induced the inhibition of proliferation of the human choriocarcinoma cell line BeWo (an in vitro model of the first-trimester trophoblast) via a CB2-dependent mechanism. We have previously shown that CB2 receptor (as well as CB1) is involved in LPS-induced increased NO production which provokes toxic damage to the decidua from 7-day pregnant mice (Vercelli et al., 2009a) . Similarly, CB2 activation partially mediates LPS-induced prostaglandin synthesis by uterine explants from early pregnant mice . The results presented here are in agreement with these observations. We found that LPS stimulation of uterine explants induced PGF 2α synthesis and a reduction in tissue content of cAMP, suggesting the involvement of a G i/o protein-coupled receptor. CB2 receptor antagonism with AM630 was able to reverse LPS effects both on PGF 2α production and intracellular content of cAMP. Interestingly, these LPS effects were mimicked by treatment with m-AEA. Moreover, treatment with m-AEA reduced the tissue content of cAMP in uterine explants from CD1 CB1-KO mice both in the presence or absence of forskolin, suggesting the participation of CB2 receptor in this effect. However, it is noteworthy to mention that CB1 receptor also contributes to the effects of LPS since when both antagonists (AM251 and AM630) were used, the reversal was complete. Moreover, in the presence of forskolin, LPS treatment was unable to reduce the tissue content of cAMP in uterine strips from CD1 CB1-KO mice when compared to their CD1 WT counterparts. Interestingly, in the absence of forskolin, LPS treatment did reduce the tissue content of cAMP in uterine explants from CD1 CB1-KO mice. Taking together, these results suggest that in some contexts, CB2 receptor activation alone is sufficient to mediate LPS reduction of uterine cAMP content. In other contexts, however, the activation of both CB1 and CB2 receptors is necessary to elicit that effect.
It is well established that LPS induces an increased contractile activity by the pregnant uterus via production of pro-inflammatory cytokines (Mackler et al., 2003) , increased Ca 2+ influx (Ross et al., 2004) and prostaglandins (Hutchinson et al., 2014) . Conversely, cAMP is a well-known smooth muscle relaxant and its intracellular levels determine the degree of uterine smooth muscle contractility. Therefore, different approaches to increase myometrial cAMP levels for tocolytic purposes have been explored. The use of β 2 -adrenergic receptor agonists is the standard tocolytic measure in many hospitals worldwide; production in uterine explants. (A) Uterine explants from 7-day pregnant BALB/c mice were stimulated for 6 h with 1 μg/ml LPS. Supernatants were collected and processed for PGF 2α determination by radioimmunoassay. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 9), a ≠ b, P < 0.05. (B) Uterine explants from 7-day pregnant BALB/c mice were preincubated for 3 min with 800 μM IBMX (a nonselective phosphodiesterase inhibitor), followed by 10 min exposure to 1 μg/ml LPS. Tissue content of cAMP was measured as described in the Materials and Methods section. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 5), a ≠ b, P < 0.05. (C) Uterine explants from 7-day pregnant BALB/c mice were stimulated for 6 h with 1 μg/ml LPS in the presence or absence of 10 nM AM251 (CB1 receptor antagonist) and/or 10 nM AM630 (CB2 receptor antagonist). Supernatants were collected and processed for PGF 2α determination by radioimmunoassay. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 9), a ≠ b, P < 0.05. LPS, lipopolysaccharide; cAMP, cyclic adenosine monophosphate; PGF 2α , prostaglandin-F 2α .
however, their potentially severe side-effects are cause of concern (Landau et al., 2005; Simhan and Caritis, 2007) . Interestingly, the inhibition of phosphodiesterase type 4 (PDE4) with rolipram reduces the rate of preterm birth in a murine model (Méhats et al., 2007) . Moreover, PDE4 inhibitors show anti-inflammatory and utero-relaxant effects in human uterine smooth muscle (Oger et al., 2004) . In this context, our observations that both LPS and m-AEA reduced the tissue content of cAMP in uterine explants from early pregnant CD1 CB1-KO mice provide evidence that activation of the CB2 receptor could be involved in shifting the equilibrium from myometrial quiescence to contractility, therefore contributing to pregnancy loss. Accordingly, it has been recently reported that CB2-KO mice are resistant to LPS-induced preterm birth (Sun et al., 2014) , suggesting a deleterious role for CB2 in inflammation during pregnancy. Conversely, exposure to the endotoxin down-regulates CB2 receptor mRNA levels albeit with no changes at the protein level in the uterus of pregnant mice in a model of LPS-elicited preterm labor (Bariani et al., 2015) . Besides binding to CB1 and CB2 receptors, m-AEA is a full agonist of ligand-gated transient receptor potential vanilloid receptor type 1 (TRPV1) ion channel (Roberts et al., 2002) . Therefore, TRPV1 activation could mediate some of the effects of m-AEA that we report here. We have previously shown that AEA enhances placental NO synthesis via a TRPV1-dependent mechanism (Cella et al., 2008 ). When we evaluated the possible participation of TRPV1 in the LPS-induced reduction of cAMP tissue content of uterine explants, we found that the antagonism of this ion channel was unable to prevent the effects of the endotoxin (see Supplementary Figure 1 ). Although this observation supports the role of CB2 as mediator of LPS effects on reducing the intracellular levels of cAMP in uterine explants from pregnant mice, we cannot discard the possible involvement of other endocannabinoidbinding receptors such as GPR55 (Sharir et al., 2012) . from 7-day pregnant CD1 WT or CD1 CB1-KO mice were preincubated for 3 min with 800 μM IBMX, followed by 10 min exposure to 1 μg/ml LPS. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 12), a ≠ b, P < 0.05. (B) Uterine explants from 7-day pregnant CD1 WT or CD1 CB1-KO mice were pre-incubated for 3 min with 800 μM IBMX, followed by 10 min exposure to different concentrations of m-AEA. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 5), a ≠ b, P < 0.05. Uterine explants from 7-day pregnant BALB/c mice were pre-incubated for 3 min with 800 μM IBMX, followed by 10 min stimulation with 3.3 μM forskolin and then 10 min exposure to 1 μg/ml LPS. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 8), a≠b, P < 0.05. (B) Uterine explants from 7-day pregnant BALB/c mice were preincubated for 3 min with 800 μM IBMX, followed by 10 min stimulation with 3.3 μM forskolin and then 10 min exposure to different concentrations of m-AEA. Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 8), a ≠ b, P < 0.05. (C) Uterine explants from 7-day pregnant BALB/c mice were pre-incubated for 3 min with 800 μM IBMX, followed by 10 min stimulation with 3.3 μM forskolin and then 10 min exposure to 1 μg/ml LPS in the presence or absence of 10 nM AM251 (CB1 receptor antagonist) and/or 10 nM AM630 (CB2 receptor antagonist).Statistical analysis was performed with blocks design. Data are shown as mean ± SEM (n = 7), a ≠ b, P < 0.05. IBMX, 3-isobutyl-1-methylxanthine.
In summary, the results presented here point towards the participation of CB2 receptors in the uterotonic effect of LPS. While the extent of the involvement of CB2 receptor on LPS-induced increase uterine contractility remains to be further explored, our data suggest that LPS exerts its deleterious effects by increasing PGF 2α synthesis and diminishing cAMP intracellular content in uterine explants via a CB2 receptor-mediated mechanism.
Supplementary data
Supplementary data are available at Molecular Human Reproduction online.
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